ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 963,90
-0,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enliven Therapeutics Inc (ELVN)

  7. Enliven Therapeutics Inc (ELVN) Actualités

ELVN Enliven Therapeutics Inc

23,04
-0,77 (-3,23%)
17 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enliven Therapeutics Inc ELVN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,77 -3,23% 23,04 22:00:10
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
24,00 22,921 24,00 23,04 23,81
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202401:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:10EDGAR2Form 8-K - Current report
14/5/202422:05GLOBEEnliven Therapeutics Reports First Quarter Financial Results..
14/5/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202402:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/4/202413:55GLOBEEnliven Therapeutics Announces Positive Proof of Concept..
09/4/202422:05GLOBEEnliven Therapeutics Appoints Dr. Lori Kunkel to Board of..
28/3/202421:05GLOBEEnliven Therapeutics to Share Initial Proof of Concept Data..
19/3/202413:30GLOBEEnliven Therapeutics Announces $90 Million Private Placement..
14/3/202421:05GLOBEEnliven Therapeutics Reports Fourth Quarter and Full Year..
09/3/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:43EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:05GLOBEEnliven Therapeutics to Present at TD Cowen’s 44th Annual..
27/2/202422:02EDGAR2Form 144 - Report of proposed sale of securities
21/2/202401:35EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
16/2/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
16/2/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202421:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:15EDGAR2Form SC 13D/A - General statement of acquisition of..
01/2/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202403:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202402:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202401:58EDGAR2Form 144 - Report of proposed sale of securities
25/1/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202301:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:11EDGAR2Form 144 - Report of proposed sale of securities
22/12/202323:20EDGAR2Form 144 - Report of proposed sale of securities
22/12/202322:57EDGAR2Form 144 - Report of proposed sale of securities
21/12/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
ELVN
Enliven Therapeutics
USOTC
RVVBS
RSE Collection (GM)
NASDAQ
SPKLU
Spark I Acquisition
UNSW3
STORJUSDT
Storj
COIN
FSXUSD
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés